These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
1118 related articles for article (PubMed ID: 16595494)
41. Comparison of MR imaging and FDG-PET/CT in the differential diagnosis of benign and malignant vertebral compression fractures. Cho WI; Chang UK J Neurosurg Spine; 2011 Feb; 14(2):177-83. PubMed ID: 21214309 [TBL] [Abstract][Full Text] [Related]
42. The value of quantifying 18F-FDG uptake in thyroid nodules found incidentally on whole-body PET-CT. Bogsrud TV; Karantanis D; Nathan MA; Mullan BP; Wiseman GA; Collins DA; Kasperbauer JL; Strome SE; Reading CC; Hay ID; Lowe VJ Nucl Med Commun; 2007 May; 28(5):373-81. PubMed ID: 17414887 [TBL] [Abstract][Full Text] [Related]
43. Total lesion glycolysis as the best 18F-FDG PET/CT parameter in differentiating intermediate-high risk adrenal incidentaloma. Kim YI; Cheon GJ; Paeng JC; Cho JY; Kang KW; Chung JK; Kim EE; Lee DS Nucl Med Commun; 2014 Jun; 35(6):606-12. PubMed ID: 24598843 [TBL] [Abstract][Full Text] [Related]
44. Indeterminate thyroid cytology in an iodine-deficient population: Prevalence, operation rate, risk of malignancy anddiagnostic value of thyroid scintigraphy and Almasi CE; Frandsen AP; Erentaite D; Duch K; Zacho HD Hell J Nucl Med; 2023; 26(1):2-8. PubMed ID: 37031417 [TBL] [Abstract][Full Text] [Related]
45. Clinical significance of standardized uptake values in thyroid incidentaloma discovered by F-18 fluorodeoxyglucose positron emission tomography/computed tomography. Sager S; Vatankulu B; Sahin OE; Cınaral F; Uslu L; Baran A; Ozturk T; Sönmezoglu K J Cancer Res Ther; 2018; 14(5):989-993. PubMed ID: 30197336 [TBL] [Abstract][Full Text] [Related]
46. [Value of dual-time-point (18)F-fluorodeoxyglucose integrated positron emission and computed tomography in differentiation of malignant from benign gastrointestinal diseases]. Xu XX; Cheng J; Xu WG; Dai D; Song XY; Ma WC; Zhu L; Zhu X Zhonghua Zhong Liu Za Zhi; 2012 May; 34(5):364-8. PubMed ID: 22883458 [TBL] [Abstract][Full Text] [Related]
47. Diffuse and diffuse-plus-focal uptake in the thyroid gland identified by using FDG-PET: prevalence of thyroid cancer and Hashimoto's thyroiditis. Kurata S; Ishibashi M; Hiromatsu Y; Kaida H; Miyake I; Uchida M; Hayabuchi N Ann Nucl Med; 2007 Aug; 21(6):325-30. PubMed ID: 17705011 [TBL] [Abstract][Full Text] [Related]
48. Pattison DA; Bozin M; Gorelik A; Hofman MS; Hicks RJ; Skandarajah A J Nucl Med; 2018 May; 59(5):749-755. PubMed ID: 29025986 [No Abstract] [Full Text] [Related]
49. Differentiation between malignancy and inflammation in pulmonary ground-glass nodules: The feasibility of integrated (18)F-FDG PET/CT. Chun EJ; Lee HJ; Kang WJ; Kim KG; Goo JM; Park CM; Lee CH Lung Cancer; 2009 Aug; 65(2):180-6. PubMed ID: 19155090 [TBL] [Abstract][Full Text] [Related]
50. The role of 18F-fluorodeoxyglucose positron emission tomography/computed tomography whole body imaging in the evaluation of focal thyroid incidentaloma. Zhai G; Zhang M; Xu H; Zhu C; Li B J Endocrinol Invest; 2010 Mar; 33(3):151-5. PubMed ID: 19783895 [TBL] [Abstract][Full Text] [Related]
51. Post-PET ultrasound improves specificity of 18F-FDG-PET for recurrent differentiated thyroid cancer while maintaining sensitivity. Biermann M; Kråkenes J; Brauckhoff K; Haugland HK; Heinecke A; Akslen LA; Varhaug JE; Brauckhoff M Acta Radiol; 2015 Nov; 56(11):1350-60. PubMed ID: 25770086 [TBL] [Abstract][Full Text] [Related]
52. Prevalence and risk of cancer of focal thyroid incidentaloma identified by 18F-fluorodeoxyglucose positron emission tomography for cancer screening in healthy subjects. Chen YK; Ding HJ; Chen KT; Chen YL; Liao AC; Shen YY; Su CT; Kao CH Anticancer Res; 2005; 25(2B):1421-6. PubMed ID: 15865100 [TBL] [Abstract][Full Text] [Related]
54. Role of (18)F-fluorodeoxyglucose positron emission tomography/computed tomography in the characterization of pancreatic masses: experience from tropics. Santhosh S; Mittal BR; Bhasin D; Srinivasan R; Rana S; Das A; Nada R; Bhattacharya A; Gupta R; Kapoor R J Gastroenterol Hepatol; 2013 Feb; 28(2):255-61. PubMed ID: 23278193 [TBL] [Abstract][Full Text] [Related]
55. Evaluation of focal thyroid lesions incidentally detected in fluorine-18-fluorodeoxyglucose positron emission tomography/computed tomography images. Yaylali O; Kirac FS; Yuksel D; Marangoz E Indian J Cancer; 2014; 51(3):236-240. PubMed ID: 25494112 [TBL] [Abstract][Full Text] [Related]
56. [The application of 18F-fluorodeoxyglucose positron emission tomography in the diagnosis and staging of lung cancer]. Xu HF; Liu Y; Zhang JH; Zhou RS; Zhou FH; Yuan MH Zhonghua Jie He He Hu Xi Za Zhi; 2005 Feb; 28(2):108-11. PubMed ID: 15854393 [TBL] [Abstract][Full Text] [Related]
57. Characterization of focal hypermetabolic thyroid incidentaloma: An analysis with F-18 fluorodeoxyglucose positron emission tomography/computed tomography parameters. Lee H; Chung YS; Lee JH; Lee KY; Hwang KH World J Clin Cases; 2022 Jan; 10(1):155-165. PubMed ID: 35071515 [TBL] [Abstract][Full Text] [Related]
58. Standardized uptake value-based evaluations of solitary pulmonary nodules using F-18 fluorodeoxyglucose-PET/computed tomography. Degirmenci B; Wilson D; Laymon CM; Becker C; Mason NS; Bencherif B; Agarwal A; Luketich J; Landreneau R; Avril N Nucl Med Commun; 2008 Jul; 29(7):614-22. PubMed ID: 18528183 [TBL] [Abstract][Full Text] [Related]
59. Incidental thyroid lesions detected by FDG-PET/CT: prevalence and risk of thyroid cancer. Bae JS; Chae BJ; Park WC; Kim JS; Kim SH; Jung SS; Song BJ World J Surg Oncol; 2009 Aug; 7():63. PubMed ID: 19664272 [TBL] [Abstract][Full Text] [Related]
60. Incidental focal FDG uptake in the parotid glands on PET/CT in patients with head and neck malignancy. Seo YL; Yoon DY; Baek S; Lim KJ; Yun EJ; Cho YK; Bae WJ; Chung EJ; Kwon KH Eur Radiol; 2015 Jan; 25(1):171-7. PubMed ID: 25182627 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]